Cargando…
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
INTRODUCTION: Targeted biologic therapies demonstrate similar efficacies in rheumatoid arthritis despite distinct mechanisms of action. They also exhibit a ceiling effect, with 10% to 20% of patients achieving remission in clinical trials. None of these therapies target synovial fibroblasts, which d...
Autores principales: | Siebert, Stefan, Pratt, Arthur G., Stocken, Deborah D., Morton, Miranda, Cranston, Amy, Cole, Michael, Frame, Sheelagh, Buckley, Christopher D., Ng, Wan-Fai, Filer, Andrew, McInnes, Iain B., Isaacs, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328978/ https://www.ncbi.nlm.nih.gov/pubmed/32590730 http://dx.doi.org/10.1097/MD.0000000000020458 |
Ejemplares similares
-
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial
por: Pratt, Arthur G, et al.
Publicado: (2021) -
TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
por: Cole, M., et al.
Publicado: (2021) -
Plasma and Synovial Fluid TrxR Levels are Correlated With Disease Risk and Severity in Patients With Rheumatoid Arthritis
por: Xie, Zhijun, et al.
Publicado: (2016) -
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial
por: Li, Ru, et al.
Publicado: (2016) -
Interleukin-22 Secreted by NKp44+ Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
por: Zhu, Junqing, et al.
Publicado: (2015)